David Shaw

HCV reinfection incidence among individuals treated for recent infection

G. Dore, K. Petoumenos, E. Gane, 2017, Journal of viral hepatitis.

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use

M. Hellard, G. Dore, P. Bruggmann, 2018 .

Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II‐III)

T. Pilot‐Matias, G. Foster, K. Agarwal, 2018, Journal of viral hepatitis.